Amyloid-beta clearance in Alzheimer's disease

Strong evidence continues to accumulate indicating that amyloid-beta (Aß) is a central part of Alzheimer's disease (AD) pathogenesis in spite of the negative evidence coming from failed clinical trials. Therefore, mechanisms of clearance of Aß are of great interest in understanding AD pathogene...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yazar: Robert Marr (auth)
Diğer Yazarlar: Eliezer Masliah (auth)
Materyal Türü: Elektronik Kitap Bölümü
Dil:İngilizce
Baskı/Yayın Bilgisi: Frontiers Media SA 2015
Seri Bilgileri:Frontiers Research Topics
Konular:
Online Erişim:DOAB: download the publication
DOAB: description of the publication
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
Diğer Bilgiler
Özet:Strong evidence continues to accumulate indicating that amyloid-beta (Aß) is a central part of Alzheimer's disease (AD) pathogenesis in spite of the negative evidence coming from failed clinical trials. Therefore, mechanisms of clearance of Aß are of great interest in understanding AD pathogenesis and the development of effective treatments. This topic focuses on the issues related to Aß clearance in AD. The topics covered include proteases that degrade Aß and their localization, regulation, and functions. This topic also covers issues related to clearance through uptake by glia and through low-density lipoprotein (LDL) receptor mediated mechanisms. Signal transduction related to AD pathology and clearance is also addressed. Finally, immunotherapy and other novel therapeutic approaches are discussed.
Fiziksel Özellikler:1 electronic resource (111 p.)
ISBN:978-2-88919-443-8
9782889194438
Erişim:Open Access